{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:15:03Z","timestamp":1778883303505,"version":"3.51.4"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Deprescribing benzodiazepines and related drugs (BZDR) is a challenge due to a lack of time on physicians\u2019 part, a lack of involvement of other health professionals, and the need for adapted tools. This study is based on primary care collaboration, by evaluating the effectiveness of a joint intervention between general practitioners and community pharmacists on the implementation of BZDR deprescribing in older adults.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a cluster randomized controlled trial in which each cluster will be formed by a physician-pharmacist pair. Within a cluster allocated to the intervention, the pharmacist will be trained in motivational interviewing (MI), and will offer the patient 3 interviews after inclusion by the physician. They will base their intervention on validated deprescribing guidelines. The pharmacist will receive methodological support during the first interviews. Interprofessional collaboration will be encouraged by writing reports for the physician after each interview. The following implementation outcomes will be evaluated: acceptability\/adoption, appropriateness, cost, and fidelity. They will be measured by means of sociological interviews, observations, logbooks, and cost-utility analysis. Focus groups with physicians and pharmacists will be carried out to identify levers and barriers experienced in this collaboration. Observations will be conducted with pharmacists to assess their approach of the MIs. Effectiveness outcomes will be based on medication (discontinuation or reduction of BZDR) and clinical outcomes (such as quality of life, insomnia or anxiety), assessed by health insurance databases and validated questionnaires.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This study will determine whether collaboration in primary care between physicians and pharmacists, as well as training and coaching of pharmacists in motivational interviewing, allows the implementation of BZDR deprescribing in the older adults.<\/jats:p><jats:p>This study will provide an understanding of the processes used to implement deprescribing guidelines, and the contribution of collaborative practice in implementing BZDR discontinuation. The cluster methodology will allow to assess the experience of the relationship between the different primary care actors, and the related obstacles and levers.<\/jats:p><jats:p>The results obtained will make it possible to produce guidelines on the involvement of community pharmacists in the management of substance abuse in older adults, or even to legislate new missions or care pathways.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p><jats:ext-link>ClinicalTrials.gov<\/jats:ext-link>, identifier, NCT05765656.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1228883","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T07:53:47Z","timestamp":1693468427000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of the effectiveness of a joint general practitioner-pharmacist intervention on the implementation of benzodiazepine deprescribing in older adults (BESTOPH-MG trial): protocol for a cluster-randomized controlled trial"],"prefix":"10.3389","volume":"10","author":[{"given":"Jean-Fran\u00e7ois","family":"Huon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Nizet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Caillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Lecompte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Victorri-Vigneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pascal","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the BESTOPH-MG consortium","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"key":"ref1","year":"2017"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","article-title":"Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits","volume":"331","author":"Glass","year":"2005","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.lpm.2018.10.005","article-title":"Benzodiazepine use and misuse in France","volume":"47","author":"B\u00e9nard-Laribi\u00e8re","year":"2018","journal-title":"Presse Medicale Paris Fr 1983"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11920-016-0727-9","article-title":"Benzodiazepine misuse in the elderly: risk factors, consequences, and management","volume":"18","author":"Airagnes","year":"2016","journal-title":"Curr Psychiatry Rep"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/gerona\/62.10.1172","article-title":"Medication as a risk factor for falls: critical systematic review","volume":"62","author":"Hartikainen","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pharma.2011.10.002","article-title":"Relationship between benzodiazepines use and falls in the elderly: a multicenter study in three geriatric centers of a university hospital","volume":"70","author":"Uhart","year":"2012","journal-title":"Ann Pharm Fr"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1532-5415.1999.tb01898.x","article-title":"Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs","volume":"47","author":"Leipzig","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study","volume":"349","author":"Billioti de Gage","year":"2014","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s40264-020-00992-7","article-title":"Patterns of benzodiazepine use and excess risk of all-cause mortality in the elderly: a Nationwide cohort study","volume":"44","author":"Mathieu","year":"2021","journal-title":"Drug Saf"},{"key":"ref10","year":""},{"key":"ref11","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/bcp.14525","article-title":"Deprescribing: what do we know, and where to next?","volume":"87","author":"Gnjidic","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s40266-022-00978-3","article-title":"Interprofessional interventions involving pharmacists and targeting the medicines management process provided to older people residing in nursing homes: a systematic review and meta-analysis of randomised controlled trials","volume":"39","author":"Sadeq","year":"2022","journal-title":"Drugs Aging"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13643-022-02027-x","article-title":"Interprofessional collaboration and patient-reported outcomes in inpatient care: a systematic review","volume":"11","author":"Kaiser","year":"2022","journal-title":"Syst Rev"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3390\/jpm12040643","article-title":"Interprofessional collaboration and diabetes Management in Primary Care: a systematic review and meta-analysis of patient-reported outcomes","volume":"12","author":"Nurchis","year":"2022","journal-title":"J Pers Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.sapharm.2017.01.003","article-title":"Self-efficacy for deprescribing: a survey for health care professionals using evidence-based deprescribing guidelines","volume":"14","author":"Farrell","year":"2018","journal-title":"Res Soc Adm Pharm RSAP"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e0151066","DOI":"10.1371\/journal.pone.0151066","article-title":"Challenges and enablers of deprescribing: a general practitioner perspective","volume":"11","author":"Ailabouni","year":"2016","journal-title":"PloS One"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s40266-022-00967-6","article-title":"Primary-care prescribers\u2019 perspectives on deprescribing opioids and benzodiazepines in older adults","volume":"39","author":"Niznik","year":"2022","journal-title":"Drugs Aging"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e022046","DOI":"10.1136\/bmjopen-2018-022046","article-title":"Intervention to reduce benzodiazepine prescriptions in primary care, study protocol of a hybrid type 1 cluster randomised controlled trial: the BENZORED study","volume":"9","author":"Vicens","year":"2019","journal-title":"BMJ Open"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/hex.13392","article-title":"\u201cI just thought that it was such an impossible thing\u201d: a qualitative study of barriers and facilitators to discontinuing long-term use of benzodiazepine receptor agonists using the theoretical domains framework","volume":"25","author":"Lynch","year":"2022","journal-title":"Health Expect Int J Public Particip Health Care Health Policy"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"CD008063","DOI":"10.1002\/14651858.CD008063.pub2","article-title":"Motivational interviewing for substance abuse","volume":"5","author":"Smedslund","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.15288\/jsa.1993.54.507a","article-title":"Motivational interviewing, preparing people to change addictive behavior","volume":"54","author":"Miller","year":"1993","journal-title":"J Stud Alcohol"},{"key":"ref23","year":"2022"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","article-title":"Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda","volume":"38","author":"Proctor","year":"2011","journal-title":"Adm Policy Ment Health Ment Health Serv Res"},{"key":"ref25","year":""},{"key":"ref26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.cct.2005.01.002","article-title":"Intraclass correlation coefficients for cluster randomized trials in primary care: the cholesterol education and research trial (CEART)","volume":"26","author":"Parker","year":"2005","journal-title":"Contemp Clin Trials"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/ije\/dyz237","article-title":"A tutorial on sample size calculation for multiple-period cluster randomized parallel, cross-over and stepped-wedge trials using the shiny CRT calculator","volume":"49","author":"Hemming","year":"2020","journal-title":"Int J Epidemiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5334\/irsp.90","article-title":"Keep calm and learn multilevel logistic modeling: a simplified three-step procedure using Stata, R, Mplus, and SPSS","volume":"30","author":"Sommet","year":"2017","journal-title":"Int Rev Soc Psychol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1745-6215-15-139","article-title":"The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies","volume":"15","author":"Kahan","year":"2014","journal-title":"Trials"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/fampra\/11.4.358","article-title":"Benzodiazepine prescribing and withdrawal for 3234 patients in 15 general practices","volume":"11","author":"Holden","year":"1994","journal-title":"Fam Pract"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0738-3991(03)00141-1","article-title":"Motivational interviewing in health settings: a review","volume":"53","author":"Britt","year":"2004","journal-title":"Patient Educ Couns"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2165\/00019053-200624070-00007","article-title":"Tapering off benzodiazepines in long-term users","volume":"24","author":"Voshaar","year":"2006","journal-title":"Pharmaco Econ"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.3390\/ijerph20043543","article-title":"Deprescribing as an opportunity to facilitate patient-Centered care: a qualitative study of general practitioners and pharmacists in Japan","volume":"20","author":"Ie","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"ref34","first-page":"584","article-title":"Tapering opioids using motivational interviewing","volume":"64","author":"Crawley","year":"2018","journal-title":"Can Fam Physician"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s12877-023-04155-y","article-title":"Outcomes in deprescribing implementation trials and compliance with expert recommendations: a systematic review","volume":"23","author":"Nizet","year":"2023","journal-title":"BMC Geriatr"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100596","article-title":"Efficacy of motivational-interviewing and guided opioid tapering support for patients undergoing orthopedic surgery (MI-opioid taper): a prospective, assessor-blind, randomized controlled pilot trial","author":"Hah","year":"2020","journal-title":"eClinicalMedicine"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jpain.2016.11.003","article-title":"Prescription opioid taper support for outpatients with chronic pain: a randomized controlled trial","volume":"18","author":"Sullivan","year":"2017","journal-title":"J Pain"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13012-022-01206-7","article-title":"Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework","volume":"17","author":"Evrard","year":"2022","journal-title":"Implement Sci"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.pec.2021.06.021","article-title":"Barriers and enablers of older adults initiating a deprescribing conversation","volume":"105","author":"Ailabouni","year":"2022","journal-title":"Patient Educ Couns"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/gps.930070205","article-title":"Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents","volume":"7","author":"Salzman","year":"1992","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/00004714-200002000-00017","article-title":"Cognitive improvement after benzodiazepine discontinuation","volume":"20","author":"Salzman","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/01.yco.0000165594.60434.84","article-title":"The diagnosis and management of benzodiazepine dependence","volume":"18","author":"Ashton","year":"2005","journal-title":"Curr Opin Psychiatry"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1017\/S0033291703008213","article-title":"Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life","volume":"33","author":"Curran","year":"2003","journal-title":"Psychol Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.addbeh.2004.03.003","article-title":"Symptom severity and quality of life after benzodiazepine withdrawal treatment in participants with complicated dependence","volume":"29","author":"Vorma","year":"2004","journal-title":"Addict Behav"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1001\/jama.2013.5592","article-title":"Patients\u2019 responsibility to participate in decision making and research","volume":"309","author":"Tinetti","year":"2013","journal-title":"JAMA"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2016.12.021","article-title":"Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action","volume":"38","author":"Reeve","year":"2017","journal-title":"Eur J Intern Med"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"20420986221118144","DOI":"10.1177\/20420986221118143","article-title":"Motivating deprescribing conversations for patients with Alzheimer\u2019s disease and related dementias: a descriptive study","volume":"13","author":"Antonelli","year":"2022","journal-title":"Ther Adv Drug Saf"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2018.16131","article-title":"Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial","volume":"320","author":"Martin","year":"2018","journal-title":"JAMA"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMra1510059","article-title":"Pragmatic trials","volume":"375","author":"Ford","year":"2016","journal-title":"N Engl J Med"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"e00476","DOI":"10.1002\/prp2.476","article-title":"Health professionals\u2019 and researchers\u2019 opinions on conducting clinical deprescribing trials","volume":"7","author":"Clough","year":"2019","journal-title":"Pharmacol Res Perspect"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2288-3-28","article-title":"Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity","volume":"3","author":"Godwin","year":"2003","journal-title":"BMC Med Res Methodol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1228883\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T07:53:52Z","timestamp":1693468432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1228883\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":52,"alternative-id":["10.3389\/fmed.2023.1228883"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1228883","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,25]]},"article-number":"1228883"}}